Buechner, S A <br/><br/>
Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicide.  [electronic resource] 

 -  The Journal of clinical investigation  Dec 1997 
 - 2691-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0021-9738 
<br/><br/><label>Standard No.: </label>10.1172/JCI119814  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis<br/>Carcinoma, Basal Cell--metabolism<br/>DNA Fragmentation<br/>Fas Ligand Protein<br/>Humans<br/>Immunoenzyme Techniques<br/>Injections<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Lymphoid Tissue<br/>Membrane Glycoproteins--metabolism<br/>Recombinant Proteins<br/>fas Receptor--metabolism